Fiche publication
Date publication
avril 2016
Journal
European journal of gastroenterology & hepatology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BRONOWICKI Jean-Pierre
Tous les auteurs :
Adhoute X, Pénaranda G, Raoul JL, Blanc JF, Edeline J, Conroy G, Perrier H, Pol B, Bayle O, Monnet O, Beaurain P, Muller C, Castellani P, Bronowicki JP, Bourlière M
Lien Pubmed
Résumé
Advanced hepatocellular carcinoma (HCC) includes a wide spectrum of tumors and patients' prognosis after treatment is highly variable. Moreover, therapeutic options based on the Barcelona Clinic Liver Cancer (BCLC) staging system algorithm are restricted to one systemic therapy.
Mots clés
Aged, Algorithms, Angiogenesis Inhibitors, therapeutic use, Area Under Curve, Carcinoma, Hepatocellular, drug therapy, Chi-Square Distribution, Decision Support Techniques, Female, France, Humans, Kaplan-Meier Estimate, Liver Neoplasms, drug therapy, Male, Middle Aged, Multivariate Analysis, Neoplasm Staging, methods, Niacinamide, analogs & derivatives, Phenylurea Compounds, therapeutic use, Predictive Value of Tests, Proportional Hazards Models, ROC Curve, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Treatment Outcome
Référence
Eur J Gastroenterol Hepatol. 2016 Apr;28(4):433-40
